An exhaustive analysis of the mechanisms implicated in Rac1 hyperactivation revealed that this dysregulated signal is independent of P-Rex1 activity or other Rac-GEFs expressed in prostate cancer cells. This evidence concerns the gene RAC1 and prostate carcinoma.